Moneycontrol
    Moneycontrol PRO
    LAMF
    LAMF

    Biocon shares fall 2.01%; stock among top losers on Nifty Midcap 150

    With the stock's last traded price at Rs 386.70, Biocon has seen a decline during today's session.
    Alpha Desk
    July 22, 2025 / 15:32 IST
    Disclaimer This is an AI-assisted live blog with updates from multiple sources Disclaimer
    Biocon shares fall 2.01%; stock among top losers on Nifty Midcap 150

    Shares of Biocon experienced a decline of 2.01% to Rs 386.70 in Tuesday's session, with the stock figuring among the top losers on the Nifty Midcap 150. This movement reflects a decrease from its previous close.

    Financial Snapshot

    The following table presents a summary of the company's consolidated financial performance:
    ParticularsMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
    Revenue (Rs Crore)7,105.808,184.0011,174.2014,755.7015,261.70
    Net Profit (Rs Crore)925.40978.50810.001,382.001,429.40
    EPS6.245.443.888.558.46
    The company's consolidated revenue increased by 3.43%, from Rs 14,755.70 Crore in March 2024 to Rs 15,261.70 Crore in March 2025. Net profit also saw an increase of 3.43%, rising from Rs 1,382.00 Crore to Rs 1,429.40 Crore during the same period. Basic EPS stood at Rs 8.46 in March 2025.

    Quarterly Financial Highlights

    Here’s a look at the consolidated quarterly performance of Biocon:
    ParticularsMar 2024Jun 2024Sep 2024Dec 2024Mar 2025
    Revenue (Rs Crore)3,917.103,432.903,590.403,821.404,417.00
    Net Profit (Rs Crore)225.60861.8027.1081.10459.40
    EPS1.135.51-0.130.212.88
    The revenue for the quarter-ending March 2025 stood at Rs 4,417.00 Crore, a 12.76% increase from Rs 3,917.10 Crore in the quarter-ending March 2024. The net profit for the quarter-ending March 2025 was Rs 459.40 Crore, compared to Rs 225.60 Crore in the corresponding quarter of the previous year.

    Key Financial Ratios (Consolidated)

    RatioMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
    Debt to Equity (x)0.470.580.990.800.82
    Return on Networth / Equity (%)9.837.692.585.164.68
    P/E (x)65.5361.6953.1830.8940.39
    The company reported a debt-to-equity ratio of 0.82 as of March 2025, slightly higher than the 0.80 reported in March 2024. The return on net worth stood at 4.68% as of March 2025. The P/E ratio is 40.39 as of March 2025.

    Corporate Actions

    Biocon announced a final dividend of Rs 0.50 per share (10%) on May 8, 2025, with an ex-date of July 4, 2025. The company had also announced bonus issues in the past, including a 1:1 bonus on April 25, 2019. Prior to that, a bonus issue of 2:1 was announced on April 27, 2017.
    With the stock's last traded price at Rs 386.70, Biocon has seen a decline during today's session.
    Alpha Desk
    first published: Jul 22, 2025 03:32 pm

    Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

    Subscribe to Tech Newsletters

    • On Saturdays

      Find the best of Al News in one place, specially curated for you every weekend.

    • Daily-Weekdays

      Stay on top of the latest tech trends and biggest startup news.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347